As a researcher, I speak with the media about evidence related to sexual and reproductive health policy and equity, including restrictive abortion policymaking (at the state and federal level) in the US and the health consequences of restrictive abortion laws. Check out some of those interviews and select press coverage of my research below!
Credit: Phyllis Iller
Select Press Coverage
-
"Arizona’s now-repealed abortion ban serves as a cautionary tale for reproductive health care across the US." The Conversation. May 2024.
"What's Next? 7 Ways the Roe v. Wade Reversal Will Impact Health in America." Good Housekeeping. July 2022.
"Denying abortion access has a negative impact on children and families." The Conversation. May 2022.
-
"Abortion Laws Affect Health in More Ways Than You Think." Prevention. August 2023.
"Georgia doctors on mifepristone rulings: 'This is not going away. It is just changing'." Georgia Public Broadcasting. April 2023.
"Emory University study shows impact of Georgia's abortion law on women." 11 Alive News. March 2023.
"Study: About 9% of would-be abortions eligible under new Georgia law." Atlanta Journal Constitution. March 2023.
"Abortion pills are safe to prescribe without in-person exams, new research finds." The Conversation. March 2022.
-
"In courtrooms and capitols, battles heat up over 'abortion pill reversal'." NBC News. July 20, 2024.
"How a San Diego doctor led the antiabortion movement to embrace controversial pill 'reversal'." Los Angeles Times. June 2024.
"Abortion opponents push state lawmakers to promote unproven ‘abortion reversal’." Stateline. November 2023.
"Colorado becomes the first state to ban controversial abortion pill reversals." KFF Health News. May 2023.
-
"SCOTUS abortion pill hearing puts FDA discretion on trial." Axios. March 2024.
"Experts Offer Vital Insights on Mifepristone Safety, Efficacy, and Access." Rollins News. March 2024.
For media requests, please contact Rob Spahr, Associate Director Media Relations at Rollins School of Public Health.